Daniel Olson
Assistant Professor, Oncology, the University of Chicago @UChicago Medicine
Signup · Get unlimited contacts
WORK HISTORY
Assistant Professor, Oncology, the University of Chicago @UChicago Medicine
Chicago, IL, US
EDUCATION
Miami University
BA
Loyola University Chicago
Post-baccalaureate Pre-Health Sciences
Northwestern University
Internal Medicine Residency
Rush University
MD
University of Chicago
Medical Oncology Fellowship
ABOUT DANIEL OLSON
My research focuses on advancing immunotherapeutic approaches to the treatment of solid tumors, with a particular focus on adoptive cell therapy. I have dedicated clinical expertise in cutaneous oncology and sarcomas, though I treat all solid tumors through clinical research in early phase drug development. I helped to complete and report a practice-changing study of anti-PD-1 plus low-dose ipilimumab after prior anti-PD-1 failure in advanced melanoma. Within my institution, I am leading multiple immunotherapy clinical trials including tumor-infiltrating lymphocyte (TILs), TCR T cell, and CAR-T cell therapies. I co-lead one of the largest TIL centers for melanoma in the country. I also lead studies targeting immune checkpoints and agonists (DGKz, CCR8, cytokines), innate immune agonists (STING) as well as oncolytic virus therapies. I have also contributed to translational research relating to biomarkers of immunotherapy response and immune-related adverse events (irAEs) to immune checkpoint therapy.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.